FINWIRES · TerminalLIVE
FINWIRES

殼牌公司認為荷蘭環保組織的訴訟“不切實際,不合理”

-- 荷蘭環保組織Milieudefensie對殼牌公司(SHEL)提起新的訴訟,試圖禁止該公司在荷蘭進行任何新的油氣開發。週二,殼牌公司發表聲明稱,Milieudefensie的訴訟「不切實際、不合理,而且從根本上就是錯誤的」。 據報道,Milieudefensie表示,殼牌必須停止鑽探新的油氣田,以減少破壞氣候的活動,並要求該公司根據《巴黎協定》在2030年至2050年間減少碳排放。 殼牌回應稱,該訴訟“忽略了油氣在未來幾十年將繼續發揮的作用”,並且“脫離了全球能源系統的現實”。 該公司表示:“隨著可再生能源的持續增長和普及,未來幾年仍需要對油氣開發進行投資,以抵消自然衰退並確保能源供應安全。” 殼牌也強調,停止油田開發並不會減少全球碳排放,因為生產權只會轉移到其他公司。 殼牌公司表示,由於資源歸各國所有,「如何開發其自然資源應由各國政府決定,而非法國環境組織Milieudefensie」。 2024年,海牙上訴法院駁回了Milieudefensie對殼牌公司的首起訴訟。該訴訟要求殼牌公司到2030年將排放量在2019年的基礎上減少45%。 今年5月,在環保組織Milieudefensie提出上訴後,海牙最高法院將審理此案。 殼牌公司表示,其油氣產量僅佔全球總產量的2%,而國營企業則貢獻了全球一半以上的產量和60%的儲量。 殼牌公司的目標是到2030年,將天然氣和上游業務的總產量每年提高1%,液體產量達到每日約140萬桶。 殼牌公司表示,該公司已在全球低碳平台領域投資約 200 億美元,並計劃根據市場需求和政府政策擴大投資組合。

Related Articles

Asia

National Australia Bank Shares Down After Resolution of Union Court Proceedings

National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."

$ASX:NAB
Asia

Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant

Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.

$ASX:CUV
Asia

XRF Scientific Completes Acquisition of Combustion Gas Analysis Business

XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.

$ASX:XRF